119 related articles for article (PubMed ID: 21691110)
1. TGR5 sequence variation in primary sclerosing cholangitis.
Hov JR; Keitel V; Schrumpf E; Häussinger D; Karlsen TH
Dig Dis; 2011; 29(1):78-84. PubMed ID: 21691110
[TBL] [Abstract][Full Text] [Related]
2. Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis.
Hov JR; Keitel V; Laerdahl JK; Spomer L; Ellinghaus E; ElSharawy A; Melum E; Boberg KM; Manke T; Balschun T; Schramm C; Bergquist A; Weismüller T; Gotthardt D; Rust C; Henckaerts L; Onnie CM; Weersma RK; Sterneck M; Teufel A; Runz H; Stiehl A; Ponsioen CY; Wijmenga C; Vatn MH; ; Stokkers PC; Vermeire S; Mathew CG; Lie BA; Beuers U; Manns MP; Schreiber S; Schrumpf E; Häussinger D; Franke A; Karlsen TH
PLoS One; 2010 Aug; 5(8):e12403. PubMed ID: 20811628
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association analysis in primary sclerosing cholangitis.
Karlsen TH; Franke A; Melum E; Kaser A; Hov JR; Balschun T; Lie BA; Bergquist A; Schramm C; Weismüller TJ; Gotthardt D; Rust C; Philipp EE; Fritz T; Henckaerts L; Weersma RK; Stokkers P; Ponsioen CY; Wijmenga C; Sterneck M; Nothnagel M; Hampe J; Teufel A; Runz H; Rosenstiel P; Stiehl A; Vermeire S; Beuers U; Manns MP; Schrumpf E; Boberg KM; Schreiber S
Gastroenterology; 2010 Mar; 138(3):1102-11. PubMed ID: 19944697
[TBL] [Abstract][Full Text] [Related]
4. Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis.
Stallhofer J; Denk GU; Glas J; Laubender RP; Göke B; Rust C; Brand S; Pusl T
Digestion; 2011; 84(1):29-35. PubMed ID: 21304239
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.
Ellinghaus D; Folseraas T; Holm K; Ellinghaus E; Melum E; Balschun T; Laerdahl JK; Shiryaev A; Gotthardt DN; Weismüller TJ; Schramm C; Wittig M; Bergquist A; Björnsson E; Marschall HU; Vatn M; Teufel A; Rust C; Gieger C; Wichmann HE; Runz H; Sterneck M; Rupp C; Braun F; Weersma RK; Wijmenga C; Ponsioen CY; Mathew CG; Rutgeerts P; Vermeire S; Schrumpf E; Hov JR; Manns MP; Boberg KM; Schreiber S; Franke A; Karlsen TH
Hepatology; 2013 Sep; 58(3):1074-83. PubMed ID: 22821403
[TBL] [Abstract][Full Text] [Related]
6. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
[TBL] [Abstract][Full Text] [Related]
7. Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.
Bowlus CL; Karlsen TH; Broomé U; Thorsby E; Vatn M; Schrumpf E; Lie BA; Boberg KM
J Hepatol; 2006 Nov; 45(5):704-10. PubMed ID: 16750586
[TBL] [Abstract][Full Text] [Related]
8. Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients.
Wiencke K; Louka AS; Spurkland A; Vatn M; Schrumpf E; Boberg KM;
J Hepatol; 2004 Aug; 41(2):209-14. PubMed ID: 15288468
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis.
Reich M; Spomer L; Klindt C; Fuchs K; Stindt J; Deutschmann K; Höhne J; Liaskou E; Hov JR; Karlsen TH; Beuers U; Verheij J; Ferreira-Gonzalez S; Hirschfield G; Forbes SJ; Schramm C; Esposito I; Nierhoff D; Fickert P; Fuchs CD; Trauner M; García-Beccaria M; Gabernet G; Nahnsen S; Mallm JP; Vogel M; Schoonjans K; Lautwein T; Köhrer K; Häussinger D; Luedde T; Heikenwalder M; Keitel V
J Hepatol; 2021 Sep; 75(3):634-646. PubMed ID: 33872692
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
[TBL] [Abstract][Full Text] [Related]
11. CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis.
Eri R; Jonsson JR; Pandeya N; Purdie DM; Clouston AD; Martin N; Duffy D; Powell EE; Fawcett J; Florin TH; Radford-Smith GL
Genes Immun; 2004 Sep; 5(6):444-50. PubMed ID: 15215889
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.
Bergquist A; Montgomery SM; Bahmanyar S; Olsson R; Danielsson A; Lindgren S; Prytz H; Hultcrantz R; Lööf LA; Sandberg-Gertzén H; Almer S; Askling J; Ehlin A; Ekbom A
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):939-43. PubMed ID: 18674735
[TBL] [Abstract][Full Text] [Related]
13. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
Gallegos-Orozco JF; E Yurk C; Wang N; Rakela J; Charlton MR; Cutting GR; Balan V
Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035
[TBL] [Abstract][Full Text] [Related]
14. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.
Joo M; Abreu-e-Lima P; Farraye F; Smith T; Swaroop P; Gardner L; Lauwers GY; Odze RD
Am J Surg Pathol; 2009 Jun; 33(6):854-62. PubMed ID: 19295408
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis.
Karlsen TH; Lie BA; Frey Frøslie K; Thorsby E; Broomé U; Schrumpf E; Boberg KM
Gastroenterology; 2006 Sep; 131(3):781-7. PubMed ID: 16952547
[TBL] [Abstract][Full Text] [Related]
16. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.
Glas J; Stallhofer J; Ripke S; Wetzke M; Pfennig S; Klein W; Epplen JT; Griga T; Schiemann U; Lacher M; Koletzko S; Folwaczny M; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1737-44. PubMed ID: 19455118
[TBL] [Abstract][Full Text] [Related]
17. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
[TBL] [Abstract][Full Text] [Related]
18. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.
Shetty K; Rybicki L; Brzezinski A; Carey WD; Lashner BA
Am J Gastroenterol; 1999 Jun; 94(6):1643-9. PubMed ID: 10364038
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1.
Yang X; Cullen SN; Li JH; Chapman RW; Jewell DP
J Hepatol; 2004 Mar; 40(3):375-9. PubMed ID: 15123348
[TBL] [Abstract][Full Text] [Related]
20. Genetics in primary sclerosing cholangitis.
Folseraas T; Melum E; Franke A; Karlsen TH
Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):713-26. PubMed ID: 22117637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
